Impact Factor 2.349 | CiteScore 2.20
More on impact ›
Pediatric Hematology and Hematological Malignancies publishes articles that range from experimental basic research studies to all aspects of clinical medicine of benign and malignant pediatric disorders affecting or originating from the hematopoietic system.Read More
Pediatric Hematology and Hematological Malignancies publishes articles that range from experimental basic research studies to all aspects of clinical medicine of benign and malignant pediatric disorders affecting or originating from the hematopoietic system.
Our goal is to provide an opportunity for pediatric investigators to report novel breakthroughs in basic, translational and clinical research of hematopoietic diseases. A special focus will be on studies that aim to establish and develop precision medicine approaches (genomics, epigenomics) in pediatric hematology, their integration into the next generation of clinical trials and novel therapeutic approaches such as cellular therapies. We encourage the submission of papers investigating the pathogenesis of lymphoid or myeloid tumors in childhood, bone marrow failure syndromes with and without associated immunodeficiencies and autoimmune diseases, or other associated diseases. We are open to case reports of rare diseases with extensive biological and genetic studies that point towards novel biological concepts. In addition to primary research papers, we welcome focused reviews on recent scientific and clinical advances and open debates. Our goal is to provide a fair and rapid peer review in order to publish scientific advances of interest to the pediatric hematology community and to promote the development of new therapeutic options for children and adolescents affected by hematological diseases.
Indexed in: PubMed, PubMed Central, Web of Science, Google Scholar, DOAJ, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Pediatric Hematology and Hematological Malignancies welcomes submissions of the following article types: Case Report, Classification, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Pediatric Hematology and Hematological Malignancies, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Pediatric Hematology and Hematological Malignancies will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Pediatrics.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com